Stocks
Wednesday, 24 Apr 2024
SUNZEN BIOTECH BHD
- Board : Ace
- Stock Code : 0148
- 52 Week High : 0.350
- 52 Week Low : 0.190
| Open | High | Low | Last | Chg | Chg % | Vol ('00) | Buy/Vol ('00) | Sell/Vol ('00) |
| 0.305 | 0.310 | 0.305 | 0.310 | 0.005 | 1.64 | 3,262 | .310 / 1,250 | .315 / 1,423 |
Log in to save your chart settings and more
- View Chart:
- 3 months
- 1 day
Financial Results
| Date Announced |
Financial Year End |
QTR | Period End | Revenue RM (,000) |
P&L RM (,000) |
EPS |
| 29 Feb 2024 | 30 Jun 2024 | 2 | 31 Dec 2023 | 29,338 | 3,593 | .44 |
| 29 Nov 2023 | 31 Dec 2023 | 3 | 30 Sep 2023 | 25,982 | 2,105 | .24 |
| 30 Aug 2023 | 31 Dec 2023 | 2 | 30 Jun 2023 | 19,775 | 1,035 | .13 |
| 26 May 2023 | 31 Dec 2023 | 1 | 31 Mar 2023 | 23,035 | 1,247 | .15 |
| 23 Feb 2023 | 31 Dec 2022 | 4 | 31 Dec 2022 | 17,036 | 1,188 | .16 |
Related News
SUNZEN BIOTECH BERHAD
The principal activities of the Company are investment holding and manufacturing of animal health products. The principal activities of its subsidiaries are distribution and marketing of animal health products and R&D and commercialisation of in-feed anti bacterial products and supplements for animal health production.
Address
10TH FLOOR, MENARA HAP SENG,NO. 1 & 3, JALAN P. RAMLEE,KUALA LUMPUR, FEDERAL TERRITORY
Malaysia
Contact
(60) 3 2382 4288
(60) 3 2382 4170
| 31 Dec 2020RM'000 | 31 Dec 2021RM'000 | 31 Dec 2022RM'000 | |
| Income Statement | |||
| Net Turnover/Net Sales | 82,233 | 90,479 | 97,094 |
| EBITDA | -13,174 | 4,316 | 10,152 |
| EBIT | -12,846 | 1,733 | 7,397 |
| Net Profit | -13,229 | 680 | 3,749 |
| BALANCE SHEET | |||
| Intangibles | 66 | 2,881 | 2,853 |
| Fixed Assets | 47,278 | 47,095 | 46,459 |
| Long Term Investment | - | - | - |
| Stocks/Inventories | 12,269 | 13,976 | 11,329 |
| Cash | 38,736 | 47,223 | 8,961 |
| Current Liabilities | 21,605 | 14,612 | 12,873 |
| Long Term Debt | 4,742 | 4,614 | 4,492 |
| Provisions | - | - | - |
| Minorities | - | - | - |
| Total Shareholders Equity | 93,484 | 125,468 | 129,709 |
| KEY RATIOS | |||
| Operating Margin(%) | -14.71 | 4.38 | 7.9 |
| Return on Equity Capital(%) | -13.88 | 0.62 | 2.94 |
| Net Profit Margin | -16.09 | 0.75 | 3.86 |
| Current Ratio | 3.51 | 5.18 | 3.53 |
| Debt to Capital at Book | 0.12 | 0.04 | 0.03 |
World'Vest Base, Inc.© 2024
Under no circumstances this document is to be used or considered as an offer to sell, or a solicitation of any offer to buy, any security. While information contained herein has been obtained from sources believed to be reliable, WVB does not represent that it is accurate or complete and it should not be relied upon as such.
1335, North Dearborn Parkway, Chicago, IL 60610
Tel: +1-312-922-4201 | Fax: 1-312-922-3277 | Email: inforequest@wvb.com
Financial Data Owned and Supplied by World'vest Base Inc. Copyright , All Rights Reserved.
| Company | Date announced |
To those registered by |
To be paid on |
Dividend | Ex-Dates |
| 24 Nov 2017 | 12 Dec 2017 | 27 Dec 2017 | Interim Single Tier 0.3sen | 08 Dec 2017 |
